DK400284D0 - 3-(piperidinyl)-og 3-(pyrrolidinyl)-1h-indazoler eller salte deraf,deres fremstilling og deres anvendelse som laegemidler - Google Patents

3-(piperidinyl)-og 3-(pyrrolidinyl)-1h-indazoler eller salte deraf,deres fremstilling og deres anvendelse som laegemidler

Info

Publication number
DK400284D0
DK400284D0 DK4002/84A DK400284A DK400284D0 DK 400284 D0 DK400284 D0 DK 400284D0 DK 4002/84 A DK4002/84 A DK 4002/84A DK 400284 A DK400284 A DK 400284A DK 400284 D0 DK400284 D0 DK 400284D0
Authority
DK
Denmark
Prior art keywords
indazoles
pyrrolidinyl
piperidinyl
medicines
salts
Prior art date
Application number
DK4002/84A
Other languages
English (en)
Other versions
DK400284A (da
Inventor
T Strupczewski Joseph
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of DK400284D0 publication Critical patent/DK400284D0/da
Publication of DK400284A publication Critical patent/DK400284A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK400284A 1983-08-22 1984-08-21 3-(piperidinyl)- og 3-(pyrrolidinyl)-1h-indazoler eller salte deraf, deres fremstilling og deres anvendelse som laegemidler DK400284A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52508883A 1983-08-22 1983-08-22

Publications (2)

Publication Number Publication Date
DK400284D0 true DK400284D0 (da) 1984-08-21
DK400284A DK400284A (da) 1985-02-23

Family

ID=24091865

Family Applications (1)

Application Number Title Priority Date Filing Date
DK400284A DK400284A (da) 1983-08-22 1984-08-21 3-(piperidinyl)- og 3-(pyrrolidinyl)-1h-indazoler eller salte deraf, deres fremstilling og deres anvendelse som laegemidler

Country Status (17)

Country Link
EP (1) EP0135781B1 (da)
JP (1) JPS60100573A (da)
KR (1) KR880002356B1 (da)
AT (1) ATE47139T1 (da)
AU (1) AU575846B2 (da)
CA (1) CA1292232C (da)
DE (1) DE3480091D1 (da)
DK (1) DK400284A (da)
ES (2) ES535289A0 (da)
FI (1) FI82242C (da)
GR (1) GR80160B (da)
HU (1) HU198036B (da)
IL (1) IL72743A (da)
NZ (1) NZ209279A (da)
PH (1) PH22032A (da)
PT (1) PT79110B (da)
ZA (1) ZA846485B (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0181793B1 (fr) * 1984-10-16 1988-07-27 Synthelabo Dérivés de pipéridine, leur préparation et leur application en thérapeutique
DE3677609D1 (de) * 1985-01-23 1991-04-04 Hoechst Roussel Pharma 3-piperidinyl- 1h-indazole, verfahren zu deren herstellung und deren anwendung als arzneimittel.
US4999356A (en) * 1987-08-07 1991-03-12 Hoechst-Roussel Pharmaceuticals, Inc. 1-phenyl-3-(1-piperazinyl)-1H-indazoles
GB8811299D0 (en) * 1988-05-12 1988-06-15 Grayshan R Indazole derivatives
US4957916A (en) * 1988-08-05 1990-09-18 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
NZ230045A (en) * 1988-08-05 1990-11-27 Janssen Pharmaceutica Nv 3-piperazinylbenzazole derivatives and pharmaceutical compositions
US5015740A (en) * 1988-08-05 1991-05-14 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
IL90879A0 (en) * 1988-09-02 1990-02-09 Janssen Pharmaceutica Nv 3-piperidinyl-indazole derivatives,their preparation and antihypertensive compositions containing them
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
DE69021645T2 (de) * 1989-05-19 1996-02-22 Hoechst-Roussel Pharmaceuticals Inc., Somerville, N.J. N-(aryloxyalkyl)heteroarylpiperidine und -heteroarylpiperazine, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente.
US5561128A (en) * 1989-05-19 1996-10-01 Hoechst-Roussel Pharmaceuticals, Inc. N-[(4-(heteroaryl)-1-piperidinyl)alkyl]-10,11-dihydro-5H-dibenz[B,F]azepines and related compounds and their therapeutic utility
US5364866A (en) * 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
DK181190D0 (da) * 1990-07-30 1990-07-30 Lundbeck & Co As H 3-aryl-indol- eller 3-aryl-indazolderivater
US5051430A (en) * 1990-09-10 1991-09-24 Hoechst-Roussel Pharmaceuticals Incorporated 3-(1H-indazol-3-yl)-4-pyridinamines
NZ243065A (en) 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
DK55192D0 (da) * 1992-04-28 1992-04-28 Lundbeck & Co As H 1-piperazino-1,2-dihydroindenderivater
EP0665840A1 (en) * 1992-10-23 1995-08-09 MERCK SHARP & DOHME LTD. Dopamine receptor subtype ligands
DE69325662T2 (de) * 1992-10-23 2000-02-10 Merck Sharp & Dohme Ltd., Hoddesdon Dopamin rezeptor subtyp liganden
DE4414113A1 (de) * 1994-04-22 1995-10-26 Merck Patent Gmbh 3-Indolylpiperidine
US5668148A (en) * 1995-04-20 1997-09-16 Merck & Co., Inc. Alpha1a adrenergic receptor antagonists
US6166027A (en) * 1996-10-14 2000-12-26 Bayer Aktiengesellschaft Heterocyclylmethyl-substituted pyrazole derivatives and their use for treating cardiovascular diseases
FR2767827A1 (fr) * 1997-09-03 1999-02-26 Adir Nouveaux derives de l'indole et de l'indazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
IL126745A (en) * 1997-11-04 2003-09-17 Pfizer Prod Inc Methods of preparing 4-cyano-4- (substituted indazole) cyclohexanecarboxylic acids useful as pde4 inhibitors
US6133290A (en) * 1998-07-31 2000-10-17 Eli Lilly And Company 5-HT1F agonists
WO2004069828A1 (ja) * 2003-02-04 2004-08-19 Mitsubishi Pharma Corporation ピペリジン化合物およびその医薬用途
CA2551346A1 (en) * 2003-12-31 2005-07-21 Warner-Lambert Company Llc N-substituted piperidine and piperazine derivatives
KR20070094747A (ko) 2004-11-29 2007-09-21 워너-램버트 캄파니 엘엘씨 치료용 피라졸로[3,4-b]피리딘 및 인다졸
UY32174A (es) * 2008-10-14 2010-05-31 Astrazeneca Ab Nuevos heterociclos sustituidos, composiciones farmaceuticas conteniendolos, procedimientos de preparacion y aplicaciones
RS57919B1 (sr) 2011-12-16 2019-01-31 Poseida Therapeutics Inc Trpc4 modulatori za primenu u lečenju ili prevenciji bola
JP2015214492A (ja) * 2012-09-07 2015-12-03 大日本住友製薬株式会社 3−(4−ピペリジル)−インダゾール誘導体
ES2924359T3 (es) * 2017-04-11 2022-10-06 Sunshine Lake Pharma Co Ltd Compuestos de indazol sustituidos con flúor y usos de los mismos

Also Published As

Publication number Publication date
FI843281A7 (fi) 1985-02-23
AU575846B2 (en) 1988-08-11
JPS60100573A (ja) 1985-06-04
AU3225084A (en) 1985-02-28
PH22032A (en) 1988-05-13
EP0135781B1 (en) 1989-10-11
NZ209279A (en) 1988-05-30
HUT37139A (en) 1985-11-28
FI843281A0 (fi) 1984-08-20
JPH051792B2 (da) 1993-01-11
ES8601964A1 (es) 1985-11-01
ZA846485B (en) 1985-03-27
ES543206A0 (es) 1986-01-01
GR80160B (en) 1984-12-19
DE3480091D1 (en) 1989-11-16
CA1292232C (en) 1991-11-19
ES8603867A1 (es) 1986-01-01
FI82242C (fi) 1991-02-11
KR880002356B1 (ko) 1988-10-29
FI82242B (fi) 1990-10-31
PT79110B (en) 1986-09-15
ES535289A0 (es) 1985-11-01
HU198036B (en) 1989-07-28
DK400284A (da) 1985-02-23
EP0135781A1 (en) 1985-04-03
IL72743A (en) 1989-01-31
KR850001748A (ko) 1985-04-01
PT79110A (en) 1984-09-01
IL72743A0 (en) 1984-11-30
ATE47139T1 (de) 1989-10-15

Similar Documents

Publication Publication Date Title
DK400284D0 (da) 3-(piperidinyl)-og 3-(pyrrolidinyl)-1h-indazoler eller salte deraf,deres fremstilling og deres anvendelse som laegemidler
DK15589A (da) Kemiske forbindelser
ES8506657A1 (es) Procedimiento para la preparacion de 3-(1-sustituido-4-piperidil)-1, 2-bencisoxazoles
NO871025L (no) Polypeptid, dna og fremgangsmaate for fremstilling derav.
IT8022331A0 (it) Essiccazione o rispettivamente per procedimento per il trattamento la calcinazione. termico, in particolare per la
EP0127167A3 (en) 3-(4-piperidinyl)-1,2-benzisothiazoles and derivates, a process for their preparation and their use as medicaments
DK336688A (da) Nucleosider od fremgangsmaade til fremstilling deraf
NO904576D0 (no) Aminopyridinylaminofenol og beslektede forbindelser, mellomprodukter, fremgangsmaate for deres fremstilling og anvendelse som medikamenter.
DK144987D0 (da) Steril, non-inflammatorisk, varmemodstandsdygtig hyaluronsyrefraktion, fremgangsmaade til fremstilling heraf og sammensaetning indeholdende samme
DK442183A (da) Thiatriazin-derivater, fremgangsmaader til fremstilling deraf og deres anvendelse som laegemidler
DK591687D0 (da) Pyrazoliner, fremstilling deraf og anvendelse deraf som middel med insekticid og akarizid virkning
NO860227L (no) 3-(piperidinyl)- og - 3-(pyrrolidinyl)-1h-indazoler og fremgangsmaate for fremstilling derav.
FR2624857B1 (fr) Derives de nicotinoyl-piperazine, procede de preparation et utilisation en therapeutique
DK179683D0 (da) N-sulfenylerede carbamater, fremgangsmade til fremstilling heraf og deres anvendelse som skadedyrbekaempelsesmiddel
IT1210421B (it) Alzacoperchio registrabile, disicurezza per ogni tipo di pentola.
DK560887D0 (da) Piperidin forbindelser, deres fremstilling og anvendelse
DK550383D0 (da) Perfluorcarbonemulsioner, fremgangsmade til fremstilling heraf og deres anvendelse som laegemidler
NO893908L (no) Anlegg for behandling av plateglass.
NO881042D0 (no) Polyuretanskum, forpolymer for dets fremstilling og nye fosfatforbindelser.

Legal Events

Date Code Title Description
ATS Application withdrawn